LDL Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED 2021
What happened to LDL (LDL) stock?
LDL (LDL) no longer trades on public markets. It was delisted in October 2021. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice.
LDL — AI-powered stock analysis.
Last analyzed: Sep 9, 2026LDL Company Overview
What Are the Key Risks for LDL?
Negative return on equity (-25.6%) — the business is not currently generating profit on shareholder capital.
- Insider selling — insiders were net sellers of roughly $5.4M recently.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 33 days old
- ● No filing on record
- ● No analyst coverage
- ● This is an unknown, not an operating company
Key Financial Metrics
Return on equity for LDL stands at -25.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.5%, showing how much profit it generates from its asset base. A current ratio of 1.86 indicates the company holds enough short-term assets to cover its near-term obligations.
Insider Activity
The most recent 12 insider filings for LDL break down as 10 sales and 2 purchases. On net that is roughly 255K shares disposed (about $5.4M), a signal worth weighing alongside the fundamentals.
LDL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
LDL Latest News
-
Dollar Stores In Earnings Spotlight; One Soars, The Other Plummets
Investor's Business Daily · Aug 26, 2026
-
NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill
seekingalpha.com · Jul 25, 2026
-
Merck's LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
businesswire.com · Jul 16, 2026
-
Stocks That Hit 52-Week Highs On Monday
· Jun 21, 2021
Latest News
Dollar Stores In Earnings Spotlight; One Soars, The Other Plummets
NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill
Merck's LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
Stocks That Hit 52-Week Highs On Monday
Common Questions About LDL
What happened to LDL (LDL) stock?
LDL (LDL) no longer trades on public markets. It was delisted in October 2021. The figures below are historical and are not a current quote.
Can I still buy LDL shares?
No. LDL stopped trading on public markets in October 2021, so the shares are not available through a broker. Anything you see quoted for LDL elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LDL stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to LDL. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.